• Return to Headlines

Shares of Life Technologies Rank the Lowest in Terms of Price to Book Ratio in the Biotechnology Industry (LIFE, INFI, PDLI, AMAG, CLDX)

By James Quinn

Below are the three companies in the Biotechnology industry with the lowest price to book ratios. Often companies with the lowest ratio present the greatest value to investors.

Life Technologies ranks lowest with a a price to book ratio of 0.46. Infinity Pharmaceuticals is next with a a price to book ratio of 0.50. PDL BioPharma ranks third lowest with a a price to book ratio of 0.88.

AMAG Pharmaceuticals follows with a a price to book ratio of 0.93, and Celldex Therapeutics rounds out the bottom five with a a price to book ratio of 1.07.

SmarTrend is tracking the current trend status for AMAG Pharmaceuticals and will alert subscribers who have AMAG in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest price to book ratio Life Technologies infinity pharmaceuticals pdl biopharma amag pharmaceuticals celldex therapeutics

Ticker(s): LIFE INFI PDLI AMAG CLDX